[144] Parker-Hannifin Corporation SEC Filing
Rhea-AI Filing Summary
What happened: A Form 144 was filed relating to Parker‑Hannifin (PH) reporting a proposed sale of 278 common shares with an aggregate market value of $204,000.
Why it matters: The shares were acquired as a stock award on 08/26/2022 and the planned sale date is 08/08/2025 on the NYSE. The filer reports no sales in the past three months and certifies they do not have undisclosed material information. This filing is a routine insider sale notice and provides transparency about an intended sale of a small number of shares.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine small insider sale notice; immaterial to company fundamentals given size.
The filing documents a proposed sale of 278 common shares with an aggregate market value of $204,000. The shares were acquired as a stock award on 08/26/2022 and the approximate sale date is 08/08/2025. With 128,410,000 shares outstanding, this transaction is immaterial from a market-capitalization perspective. The filer also indicates no sales in the past three months, which suggests this is an isolated, planned disposition rather than part of a pattern of recent insider selling.
TL;DR: Compliance-focused disclosure that meets Rule 144 requirements; no governance red flags in the notice itself.
The notice states the securities were received as compensation and lists the broker and exchange (NYSE). The filer certifies they are not aware of any undisclosed material information, a standard attestation on Form 144. There are no reported sales in the prior three months. Based solely on this filing, there is no evidence of unusual insider activity or governance concerns; it appears to be a routine, compliant disclosure.